Market Tracker

04/24 5:06am ET

Immunomedics Inc (NASDAQ:IMMU)

5.20
Delayed Data
As of Apr 21
 -0.78 / -13.04%
Today’s Change
1.95
Today|||52-Week Range
7.15
+41.69%
Year-to-Date
No recent news for Immunomedics Inc.

Today’s Trading

Previous close5.98
Today’s open5.95
Day’s range5.00 - 5.98
Volume5,162,431
Average volume (3 months)3,215,793
Market cap$551.6M
Dividend yield--
Data as of 04/21/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+2.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VIVOMeridian Bioscience ...-0.10-0.73%
LNTHLantheus Holdings In...-0.40-3.33%
ALRPRBAlere Inc-1.38-0.36%
CLDXCelldex Therapeutics...-0.06-1.84%
Data as of 04/21/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts